Georgia's Online Cancer Information Center

Suresh S. Ramalingam

Suresh S. Ramalingam, MD, FASCO

Professor of Hematology and Medical Oncology and the Roberto C. Goizueta Chair for Cancer Research a

Emory University School of Medicine and Winship Cancer Institute

Suresh S. Ramalingam, MD, FASCO

Suresh S. Ramalingam

Professor of Hematology and Medical Oncology and the Roberto C. Goizueta Chair for Cancer Research a

Emory University School of Medicine and Winship Cancer Institute

Dr. Ramalingam’s research is focused on the development of novel treatment approaches for patients with lung cancer. Specifically, his group has developed novel treatment options for lung cancer patients harboring an EGFR mutation, resulting in FDA approval of third generation inhibitors for standard therapy of metastatic NSCLC. He also leads clinical and translational investigations of novel immunotherapy approaches for the treatment of lung cancer. He has published more than 325 original manuscripts, review articles, editorials and book chapters. He serves as the principal investigator for the Emory University Lung Cancer SPORE award from the National Cancer Institute. He is also the contact principal investigator for the ECOG-ACRIN Thoracic Malignancies Translational Science Center Award from the National Cancer Institute.

As the Deputy Director of Winship Cancer Institute, Dr. Ramalingam provides oversight for the scientific research programs and leads the Scientific Research Council. Dr. Ramalingam serves as the Chair of the ECOG-ACRIN Thoracic Malignancies Committee and Deputy Chair for Therapeutics Programs at ECOG-ACRIN. He is the section editor for ‘Chest malignancies’ for ‘Cancer’ journal (American Cancer Society). Dr. Ramalingam is the recipient of several awards, including the James R. Eckman Award for Excellence at Emory University, and the Distinguished Cancer Scholar Award, Georgia Cancer Coalition. In addition, he is a recipient of the ASCO Career Development Award (2006–2009), the ECOG Young Investigator Award (2013), and the NCI ‘Clinical Investigators Team Leadership Award’ (2010-12). Dr. Ramalingam serves as a member of the board of directors for the International Association for the Study of Lung Cancer (IASLC) and as a member of the NCI Thoracic Malignancies Steering Committee. He is past president of the Georgia Society of Oncology and a former member of the Emory Healthcare board of directors.

Dr. Ramalingam received his medical degree at Kilpauk Medical College, Madras, India. He completed his residency in Internal Medicine at Wayne State University, Detroit, Michigan, where he also served as Chief Medical Resident. He then completed a fellowship in Hematology and Medical Oncology at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

About Us

Despite pandemic, Georgia’s Colorectal Cancer Control Program making significant strides

Thanks to funding awarded by the Centers for Disease Control for five-years beginning July 2020, Georgia CORE and Augusta University are partners in the Georgia Colorectal Cancer Control Program, which is increasing CRC screenings in southeast and southwest Georgia.

3/23/2021

Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.